Foresite Capital Management IV’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $19.2M | Hold |
|
|||||
|
2023
Q2 | $29.1M | Hold |
|
|||||
|
2023
Q1 | $22.7M | Hold |
|
|||||
|
2022
Q4 | $44.2M | Hold |
|
|||||
|
2022
Q3 | $44.2M | Hold |
|
|||||
|
2022
Q2 | $39.2M | Sell |
|
|||||
|
2022
Q1 | $50M | Sell |
|
|||||
|
2021
Q4 | $49.4M | Hold |
|
|||||
|
2021
Q3 | $61.2M | Hold |
|
|||||
|
2021
Q2 | $59.7M | Hold |
|
|||||
|
2021
Q1 | $85.7M | Buy |
|
|||||
|
2020
Q4 | $6.16M | Buy |
|
|||||
|
2020
Q3 | $372K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $5.53M | Buy |
|
|||||
|
2018
Q3 | $7.69M | Hold |
|
|||||
|
2018
Q2 | $10.6M | Buy |
|
|||||
|
2018
Q1 | $7.53M | Buy |
|
|||||
|
2017
Q4 | $6.21M | Buy |
|